APA (7th ed.) Citation

Sarita, K., Kumar, N., Agrawal, A., Mali, S. N., & Sharma, S. (2024). In Vitro and InSilico Evaluation of 2-(1H-Benzo[d]imidazol-2-yl)-3-(4-(piperazin-1-yl)phenyl)propanenitrile as Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors. Russian journal of bioorganic chemistry, 50(4), 1563-1572. https://doi.org/10.1134/S1068162024040174

Chicago Style (17th ed.) Citation

Sarita, K., N. Kumar, A. Agrawal, S. N. Mali, and S. Sharma. "In Vitro and InSilico Evaluation of 2-(1H-Benzo[d]imidazol-2-yl)-3-(4-(piperazin-1-yl)phenyl)propanenitrile as Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors." Russian Journal of Bioorganic Chemistry 50, no. 4 (2024): 1563-1572. https://doi.org/10.1134/S1068162024040174.

MLA (9th ed.) Citation

Sarita, K., et al. "In Vitro and InSilico Evaluation of 2-(1H-Benzo[d]imidazol-2-yl)-3-(4-(piperazin-1-yl)phenyl)propanenitrile as Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors." Russian Journal of Bioorganic Chemistry, vol. 50, no. 4, 2024, pp. 1563-1572, https://doi.org/10.1134/S1068162024040174.